DiscoverWSJ Minute BriefingEli Lilly to Offer Weight-Loss Drug Zepbound in Reduced-Cost Vials
Eli Lilly to Offer Weight-Loss Drug Zepbound in Reduced-Cost Vials

Eli Lilly to Offer Weight-Loss Drug Zepbound in Reduced-Cost Vials

Update: 2024-08-27
Share

Description

Plus: Super Micro shares decline after Hindenburg Research said it is shorting the stock. Paramount Global shares fall a day after Edgar Bronfman Jr. dropped his bid for the media giant. J.R. Whalen reports.




Sign up for the WSJ's free What's News newsletter.


Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Eli Lilly to Offer Weight-Loss Drug Zepbound in Reduced-Cost Vials

Eli Lilly to Offer Weight-Loss Drug Zepbound in Reduced-Cost Vials

The Wall Street Journal